1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis, 2016 Update

Summary

Universal Biosensors, Inc. (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI’s major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Universal Biosensors, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


Universal Biosensors, Inc. Company Snapshot 5
Universal Biosensors, Inc. Company Overview 5
Universal Biosensors, Inc. Pipeline Products and Clinical Trials Overview 6
Universal Biosensors, Inc. - Pipeline Analysis Overview 8
Business Description 8
Key Facts 8
Universal Biosensors, Inc. - Major Products and Services 9
Universal Biosensors, Inc. Pipeline Products by Development Stage 10
Universal Biosensors, Inc. Pipeline Products Overview 12
C-Reactive Protein Test 12
C-Reactive Protein Test Product Overview 12
Diagnostic Assay - Coagulation 13
Diagnostic Assay - Coagulation Product Overview 13
DNA/RNA Blood Glucose Test 14
DNA/RNA Blood Glucose Test Product Overview 14
Handheld POC Coagulation Testing System - Ambulatory Care 15
Handheld POC Coagulation Testing System - Ambulatory Care Product Overview 15
Immunoassay Test - D-Dimer 16
Immunoassay Test - D-Dimer Product Overview 16
PT-INR Testing System - Decentralised And Home Use 17
PT-INR Testing System - Decentralised And Home Use Product Overview 17
Universal Biosensors, Inc. - Key Competitors 18
Universal Biosensors, Inc. - Key Employees 19
Universal Biosensors, Inc. - Key Employee Biographies 20
Universal Biosensors, Inc. - Locations And Subsidiaries 21
Head Office 21
Other Locations and Subsidiaries 21
Recent Developments 22
Universal Biosensors, Inc., Recent Developments 22
Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 22
Oct 15, 2015: Development Update: UBI PT-INR Testing System for decentralised and home use 22
Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 23
May 13, 2015: Siemens Healthcare Diagnostics launches Xprecia Stride Coagulation Analyzer 23
Dec 17, 2014: Launch of Siemens Xprecia Stride Coagulation Analyzer for the point-of-care 24
Dec 09, 2014: Blood coagulation testing system approved for the European market 24
Sep 17, 2014: Delay to launch of new PT-INR testing system 25
Jul 24, 2014: Universal Biosensors reports total revenues of AUD2.9m in H1 2014 25
Feb 14, 2014: Universal Biosensors Announces FY2013 Financial Results 27
Oct 08, 2013: UBI Business Update 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Universal Biosensors, Inc. Pipeline Products and Clinical Trials Overview 6
Universal Biosensors, Inc. Pipeline Products by Equipment Type 6
Universal Biosensors, Inc. Pipeline Products by Indication 7
Universal Biosensors, Inc., Key Facts 8
Universal Biosensors, Inc., Major Products and Services 9
Universal Biosensors, Inc. Number of Pipeline Products by Development Stage 10
Universal Biosensors, Inc. Pipeline Products Summary by Development Stage 11
C-Reactive Protein Test - Product Status 12
C-Reactive Protein Test - Product Description 12
Diagnostic Assay - Coagulation - Product Status 13
Diagnostic Assay - Coagulation - Product Description 13
DNA/RNA Blood Glucose Test - Product Status 14
DNA/RNA Blood Glucose Test - Product Description 14
Handheld POC Coagulation Testing System - Ambulatory Care - Product Status 15
Handheld POC Coagulation Testing System - Ambulatory Care - Product Description 15
Immunoassay Test - D-Dimer - Product Status 16
Immunoassay Test - D-Dimer - Product Description 16
PT-INR Testing System - Decentralised And Home Use - Product Status 17
PT-INR Testing System - Decentralised And Home Use - Product Description 17
Universal Biosensors, Inc., Key Employees 19
Universal Biosensors, Inc., Key Employee Biographies 20
Universal Biosensors, Inc., Subsidiaries 21

List of Figures
Universal Biosensors, Inc. Pipeline Products by Equipment Type 7
Universal Biosensors, Inc. Pipeline Products by Development Stage 10

Companies Mentioned
Siemens Healthcare GmbH
Roche Diagnostics International Ltd.
Diagnostica Stago SAS
Beckman Coulter, Inc.
Bayer Corporation
Alere Inc.
Abbott Point of Care Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.